#1977101
Vacsaín in aghaidh COVID-19 nó próifiolacsas in aghaidh COVID-19
COVID-19 vaccine or prophylaxis
Vacsaín in aghaidh COVID-19 nó próifiolacsas in aghaidh COVID-19
COVID-19 vaccine or prophylaxis
Vacsaín in aghaidh COVID-19 nó próifiolacsas in aghaidh COVID-19
COVID-19 vaccine or prophylaxis
vacsaín in aghaidh COVID-19 nó próifiolacsas in aghaidh COVID-19;
COVID-19 vaccine or prophylaxis;
Eurofound COVID-19 EU PolicyWatch [Súil ar Bheartais COVID-19 an Aontais];
Eurofound COVID-19 EU PolicyWatch;
Eurofound (2021), Living, working and COVID-19, round 2 [Cónaí, obair agus COVID-19, babhta 2].
Eurofound (2021), Living, working and COVID-19 e-survey, round 2.
Le Rialachán (AE) 2021/953, leagtar síos creat chun deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (Deimhniú Digiteach COVID AE) a eisiúint agus a fhíorú agus chun go nglacfaí leo, chun feidhmiú cheart na sealbhóirí chun an tsaorghluaiseacht a éascú le linn phaindéim COVID-19.
Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic.
Le Rialachán (AE) 2021/953, leagtar síos creat chun deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (Deimhniú Digiteach COVID AE) a eisiúint agus a fhíorú agus chun go nglacfaí leo, ionas go n-éascófar do na sealbhóirí a gceart chun saorghluaiseachta a fheidhmiú le linn phaindéim COVID-19.
Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic.
Le Rialachán (AE) 2021/953, leagtar síos creat chun deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (Deimhniú Digiteach COVID AE) a eisiúint agus a fhíorú agus chun go nglacfaí leo, ionas go n-éascófar do na sealbhóirí a gceart chun saorghluaiseachta a fheidhmiú le linn phaindéim COVID-19.
Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic.
Ós rud é nach féidir leis na Ballstáit cuspóir an Rialacháin seo a ghnóthú go leordhóthanach, eadhon feidhmiú an chirt chun saorghluaiseachta laistigh den Aontas a éascú le linn phaindéim COVID-19 trí chreat a bhunú chun deimhnithe idir-inoibritheacha COVID-19 maidir le vacsaíniú in aghaidh COVID-19, toradh thástáil COVID-19 nó téarnamh ó COVID-19 maidir leis an duine a eisiúint agus a fhíorú, agus chun go nglacfaí leo, agus, de bharr fhairsinge agus éifeachtaí na gníomhaíochta, gur fearr is féidir é a ghnóthú ar leibhéal an Aontais, féadfaidh an tAontas bearta a ghlacadh, i gcomhréir le prionsabal na coimhdeachta a leagtar amach in Airteagal 5 den Chonradh ar an Aontas Eorpach.
Since the objective of this Regulation, namely to facilitate the exercise of the right to free movement within the Union during the COVID-19 pandemic by establishing a framework for the issuance, verification and acceptance of interoperable COVID-19 certificates on a person’s COVID-19 vaccination, test result or recovery, cannot be sufficiently achieved by the Member States but can rather, by reason of the scale and effects of the action, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union.
Leagtar síos leis an Rialachán seo, creat chun deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (Deimhniú Digiteach COVID AE) a eisiúint agus a fhíorú agus chun go nglacfaí leo chun feidhmiú cheart na sealbhóirí chun an tsaorghluaiseacht a éascú le linn phaindéim COVID-19.
This Regulation lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic.
Ós rud é nach féidir leis na Ballstáit cuspóir an Rialacháin seo a ghnóthú go leordhóthanach, eadhon an taisteal a dhéanann náisiúnaigh tríú tír atá ag fanacht go dleathach nó a bhfuil cónaí orthu go dleathach ar chríocha na mBallstát le linn phaindéim COVID-19 a éascú trí chreat a bhunú chun deimhnithe idir-inoibritheacha COVID-19 maidir le vacsaíniú in aghaidh COVID-19, toradh thástáil COVID-19 nó téarnamh ó COVID-19 maidir leis an duine a eisiúint agus a fhíorú, agus chun go nglacfaí leo, agus, de bharr fhairsinge agus éifeachtaí na gníomhaíochta, gur fearr is féidir é a ghnóthú ar leibhéal an Aontais, féadfaidh an tAontas bearta a ghlacadh, i gcomhréir le prionsabal na coimhdeachta a leagtar amach in Airteagal 5 CAE.
Since the objective of this Regulation, namely to facilitate the travel of third-country nationals legally staying or residing in the territories of the Member States during the COVID-19 pandemic by establishing a framework for the issuance, verification and acceptance of interoperable COVID-19 certificates on a person’s COVID-19 vaccination, test result or recovery, cannot be sufficiently achieved by the Member States but can rather, by reason of the scale and effects of the action, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 TEU.
Leagtar síos le Rialachán (AE) 2021/953 creat chun deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (“Deimhniú Digiteach COVID AE”) a eisiúint agus a fhíorú agus chun go nglacfaí leo chun feidhmiú cheart na sealbhóirí chun an tsaorghluaiseacht a éascú le linn phaindéim COVID-19.
Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic.
Leagtar síos le Rialachán (AE) 2021/953 creat chun deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (“Deimhniú Digiteach COVID AE”) a eisiúint agus a fhíorú agus chun go nglacfaí leo chun feidhmiú cheart na sealbhóirí chun an tsaorghluaiseacht a éascú le linn phaindéim COVID-19.
Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic.
Ós rud é nach féidir leis na Ballstáit cuspóir an Rialacháin seo, eadhon feidhmiú an chirt chun saorghluaiseachta laistigh den Aontas a éascú le linn phaindéim COVID-19 trí chreat a bhunú chun deimhnithe idir-inoibritheacha COVID-19 maidir le vacsaíniú duine in aghaidh COVID-19, toradh tástála duine le haghaidh COVID-19 nó téarnamh duine ó COVID-19 a eisiúint agus a fhíorú, agus chun go nglacfaí leo, a ghnóthú go leordhóthanach agus, de bharr fhairsinge agus éifeachtaí na gníomhaíochta, gur fearr is féidir é a ghnóthú ar leibhéal an Aontais, féadfaidh an tAontas bearta a ghlacadh, i gcomhréir le prionsabal na coimhdeachta a leagtar amach in Airteagal 5 den Chonradh ar an Aontas Eorpach.
Since the objective of this Regulation, namely to facilitate the exercise of the right to free movement within the Union during the COVID-19 pandemic by establishing a framework for the issuance, verification and acceptance of interoperable COVID-19 certificates on a person’s COVID-19 vaccination, test result or recovery, cannot be sufficiently achieved by the Member States but can rather, by reason of the scale and effects of the action, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union.
Ós rud é nach féidir leis na Ballstáit cuspóir an Rialacháin seo a ghnóthú go leordhóthanach, eadhon an taisteal a dhéanann náisiúnaigh tríú tír atá ag fanacht go dleathach nó a bhfuil cónaí orthu go dleathach ar chríocha na mBallstát le linn phaindéim COVID-19 a éascú trí chreat a bhunú chun deimhnithe idir-inoibritheacha COVID-19 maidir le vacsaíniú in aghaidh COVID-19, toradh thástáil COVID-19 nó téarnamh ó COVID-19 maidir leis an duine a eisiúint agus a fhíorú, agus chun go nglacfaí leo, agus, de bharr fhairsinge agus éifeachtaí na gníomhaíochta, gur fearr is féidir é a ghnóthú ar leibhéal an Aontais, féadfaidh an tAontas bearta a ghlacadh, i gcomhréir le prionsabal na coimhdeachta a leagtar amach in Airteagal 5 CAE.
Since the objective of this Regulation, namely to facilitate the travel of third-country nationals legally staying or residing in the territories of the Member States during the COVID-19 pandemic by establishing a framework for the issuance, verification and acceptance of interoperable COVID-19 certificates on a person’s COVID-19 vaccination, test result or recovery, cannot be sufficiently achieved by the Member States but can rather, by reason of the scale and effects of the action, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 TEU.
Áirithítear leis gur féidir le saoránaigh tairbhe a bhaint as deimhnithe idir-inoibritheacha a nglactar leo go frithpháirteach i ndáil le vacsaíniú COVID-19, tástáil COVID-19 agus téarnamh ó COVID-19.
It ensures that citizens can benefit from interoperable and mutually accepted certificates of COVID-19 vaccination, test and recovery.
Ar na vacsaíní sin faoi láthair tá COVILO (vacsaín BIBP i gcoinne COVID-19), vacsaín Vaxzevria i gcoinne COVID-19, vacsaín Janssen i gcoinne COVID-19, agus vacsaín Comirnaty i gcoinne COVID-19.
These currently include COVILO (COVID-19 Vaccine BIBP), Vaxzevria, COVID-19 Vaccine Janssen, and Comirnaty COVID-19 vaccine.
Le Rialachán (AE) 2021/953, leagtar síos creat chun deimhnithe idir-inoibritheacha i ndáil le vacsaíniú in aghaidh COVID-19, tástáil le haghaidh COVID-19 agus téarnamh ó COVID-19 (Deimhniú Digiteach COVID AE) a eisiúint agus a fhíorú, agus chun go nglacfaí leo chun an tsaorghluaiseacht a éascú le linn phaindéim COVID-19.
Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic.
I bhfianaise na neamhchinnteachtaí atá fós ann maidir le forbairt bhreise phaindéim COVID-19, ní féidir a eisiamh go leanfaidh na Ballstáit de cheangal a chur ar shaoránaigh an Aontais agus ar bhaill dá dteaghlaigh a fheidhmíonn a gceart chun saorghluaiseachta cruthúnas ar vacsaíniú in aghaidh COVID-19, ar thoradh tástála le haghaidh COVID-19 nó ar théarnamh ó COVID-19 a thaispeáint tar éis an 30 Meitheamh 2022, is é sin, an dáta atá Rialachán (AE) 2021/953 le dul in éag.
In view of the remaining uncertainties regarding the further evolution of the COVID-19 pandemic, it cannot be excluded that Member States continue to require Union citizens and their family members exercising their right to free movement to present proof of COVID-19 vaccination, test result or recovery after 30 June 2022, the date on which Regulation (EU) 2021/953 is due to expire.
ag tabhairt dá haire, in ainneoin na ndeacrachtaí nach bhfacthas riamh cheana ó thus phaindéim dhomhanda COVID-19 in 2020, gur lean an Ghníomhaireacht de bheith ag gníomhú ar mhaithe le sláinte phoiblí shaoránaigh uile na hEorpa nuair a bhí COVID-19 rompu, trí ghníomhú mar mhol an líonra Eorpaigh d’údaráis rialála leigheasra a dhéanann creat reachtach is infheidhme an Aontais maidir le táirgí den sórt sin a chur chun feidhme; á thabhairt chun suntais go raibh ról tábhachtach ag an nGníomhaireacht i dtaobh fhreagairt an Aontais ar phaindéim COVID-19 a ullmhú agus ag moladh na n-iarrachtaí a rinne sí chun anailís a dhéanamh go héifeachtach ar vacsaíní in aghaidh COVID-19 sna Ballstáit agus iad a fhormheas go tapa;
Notes that, despite the unprecedented difficulties since the start of the global COVID-19 pandemic in 2020, the Agency continued to act in the interests of the public health of all European citizens as they were confronted with COVID-19, by acting as the hub of the European network of regulatory medicines authorities that implements the applicable Union legislative framework for such products; highlights the important role the Agency played in preparation of the Union’s response to the COVID-19 pandemic and praises its efforts to effectively analyse and to quickly approve vaccines against COVID-19 in the Member States;
An 5 Iúil 2022, chuir Sainréigiún Riaracháin Hong Cong faisnéis mhionsonraithe ar fáil don Choimisiún maidir le heisiúint deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú, tástáil agus téarnamh faoin gcóras darb ainm “COVID-19 Electronic Vaccination and Testing Record System (eVT) [Córas Taifeadta Leictreonach i ndáil le Vacsaíniú agus Tástáil COVID-19]”. Chuir Sainréigiún Riaracháin Hong Cong an Coimisiún ar an eolas go measann sé go bhfuil a dheimhnithe COVID-19 á n-eisiúint i gcomhréir le caighdeán agus córas teicneolaíochta atá idir-inoibritheach leis an gcreat iontaoibhe a bhunaítear le Rialachán (AE) 2021/953, caighdeán agus córas teicneolaíochta lena bhféadfar barántúlacht, bailíocht agus sláine na ndeimhnithe a fhíorú.
On 5 July 2022, Hong Kong Special Administrative Region provided the Commission with detailed information on the issuance of interoperable COVID-19 vaccination, test and recovery certificates under the system entitled ‘COVID-19 Electronic Vaccination and Testing Record System (eVT)’.Hong Kong Special Administrative Region informed the Commission that it considered that its COVID-19 certificates are being issued in accordance with a standard and technological system, that are interoperable with the trust framework established by Regulation (EU) 2021/953 and that allow for the verification of the authenticity, validity and integrity of the certificates.
An 5 Iúil 2022, chuir Sainréigiún Riaracháin Hong Cong faisnéis mhionsonraithe ar fáil don Choimisiún maidir le heisiúint deimhnithe idir-inoibritheacha COVID-19 i ndáil le vacsaíniú, tástáil agus téarnamh faoin gcóras darb ainm “COVID-19 Electronic Vaccination and Testing Record System (eVT) [Córas Taifeadta Leictreonach i ndáil le Vacsaíniú agus Tástáil COVID-19]”. Chuir Sainréigiún Riaracháin Hong Cong an Coimisiún ar an eolas go measann sé go bhfuil a dheimhnithe COVID-19 á n-eisiúint i gcomhréir le caighdeán agus córas teicneolaíochta atá idir-inoibritheach leis an gcreat iontaoibhe a bhunaítear le Rialachán (AE) 2021/953, caighdeán agus córas teicneolaíochta lena bhféadfar barántúlacht, bailíocht agus sláine na ndeimhnithe a fhíorú.
On 5 July 2022, Hong Kong Special Administrative Region provided the Commission with detailed information on the issuance of interoperable COVID-19 vaccination, test and recovery certificates under the system entitled ‘COVID-19 Electronic Vaccination and Testing Record System (eVT)’.Hong Kong Special Administrative Region informed the Commission that it considered that its COVID-19 certificates are being issued in accordance with a standard and technological system, that are interoperable with the trust framework established by Regulation (EU) 2021/953 and that allow for the verification of the authenticity, validity and integrity of the certificates.
ag tabhairt dá haire ón staidéar Cost of Non-EU Agencies Focusing on the Health and Safety Cluster of the EU Decentralised Agencies [Costas Gníomhaireachtaí Neamh-AE a Dhíríonn ar Chnuasach Sláinte agus Sábháilteachta Ghníomhaireachtaí Díláraithe AE] gur léirigh seacht ngníomhaireacht an Aontais i réimse na sláinte agus na sábháilteachta breisluach láidir Eorpach agus go bhfuil sé sin aitheanta go forleathan ag na Ballstáit agus ag geallsealbhóirí eile lena n-áirítear geallsealbhóirí gnó; ag tabhairt dá haire go háirithe go raibh ról tábhachtach ag na gníomhaireachtaí sa bhraisle sláinte agus sábháilteachta i bhfreagairt an Aontais ar phaindéim COVID-19; ag tabhairt dá haire go raibh baint dhíreach ag ECDC agus EMA le dul i ngleic leis na dúshláin a d’eascair as an ngéarchéim, trí fhaireachán a dhéanamh ar shonraí eipidéimeolaíocha agus trí vacsaíní a fhormheas, agus gur chuir gníomhaireachtaí eile treoir ar fáil maidir leis na rioscaí a bhaineann leis an víreas a tholg in earnálacha áirithe a laghdú, amhail an Prótacal Sábháilteachta Sláinte Eitlíochta COVID-19 ó EASA, ráitis an Údaráis Eorpaigh um Shábháilteacht Bia (EFSA) maidir leis an mbaol go bhféadfaí víreas COVID-19 a tholg trí bhia, agus tuarascálacha na Gníomhaireachta Eorpaí um Shábháilteacht Mhuirí (EMSA) maidir le tionchar phaindéim COVID-19 ar loingseoireacht; ag tabhairt dá haire gur leag paindéim COVID-19 béim ar mhéid an chomhoibrithe idir na Gníomhaireachtaí;
Notes from the study ‘Cost of Non-EU Agencies Focusing on the Health and Safety Cluster of the EU Decentralised Agencies’ that the seven Union agencies in the health and safety field demonstrated strong European added value and that this is widely recognised by Member States and other stakeholders including business stakeholders; notes, in particular, that the agencies in the health and safety cluster have played an important role in the Union’s response to the COVID-19 pandemic; notes that the ECDC and the EMA have been directly involved in tackling challenges arising from the crisis, by monitoring epidemiological data and through the approval of vaccines, while other agencies produced guidance on reducing the risk of contracting the virus in particular sectors, such as the EASA’s COVID-19 Aviation Health Safety Protocol, the European Food Safety Authority’s (EFSA) statements on risk of contracting the COVID-19 virus through food, and the European Maritime Safety Agency’s (EMSA) reports on the impact of the COVID-19 pandemic on shipping; notes that the COVID-19 pandemic highlighted the extent of collaboration between the Agencies;
Á chur in iúl gur geal léi go háirithe na gníomhaíochtaí an-tráthúil agus an-úsáideach a rinneadh chun torthaí a bhaineann leis na hathruithe a tháinig as paindéim COVID-19 a chur in iúl, amhail teilea-obair, obair ardáin, neamhionannais inscne agus difríochtaí idirghlúine a mhéadú, ganntanais lucht saothair, cúram fadtéarmach, caidreamh tionsclaíoch, agus leas á bhaint as an ríomhshuirbhé maireachtála, oibre agus COVID-19 agus Faire Beartais an Aontais ar COVID-19, lena n-áirítear na tuarascálacha dar teideal ‘Dálaí oibre in aimsir COVID-19: Impleachtaí don todhchaí’ agus ‘Tionchar COVID-19 ar dhaoine óga in AE’; á chreidiúint gur féidir leis an bhForas ról ríthábhachtach a bheith aige maidir le hanailís bhreise a dhéanamh ar an méadú ar theilea-obair agus ar na tionchair ghaolmhara ar chothromaíocht oibre is saoil agus ar cháilíocht dálaí oibre, ar dhea-chleachtais a scaipeadh agus ar fhreagairtí beartais a d’fhéadfadh a bheith ann a mheas; á chur in iúl gur geal léi roghanna beartais an Fhorais maidir le hanailísí ar chláir oibre chun dálaí oibre, caidreamh tionsclaíoch, fostaíocht agus dálaí maireachtála a fheabhsú;
Welcomes in particular the very timely and useful actions to communicate findings relevant to the changes brought by the COVID-19 pandemic, such as teleworking, platform work, increasing gender inequalities and intergenerational differences, labour shortages, long-term care, industrial relations, drawing on the living, working and COVID-19 e-survey and the COVID-19 EU PolicyWatch, including reports entitled ‘Working conditions in the time of COVID-19: Implications for the future’ and ‘Impact of COVID-19 on young people in the EU’; believes that the Foundation can play a crucial role in further analysing the increase in telework and related impacts on work–life balance and quality of working conditions, the dissemination of best practices and assessing possible policy responses; welcomes the fact that the Foundation’s work programme analyses policy options to improve working conditions, industrial relations, employment and living conditions;
An 11 Márta 2020, dhearbhaigh EDS gur paindéim í ráig COVID-19.
On 11 March 2020, the WHO declared the COVID-19 outbreak a pandemic.
Chuaigh paindéim COVID-19 i bhfeidhm ar Bhallstáit uile an Aontais.
The COVID-19 pandemic has affected all Member States.
Meáin bhreise urghnácha shealadacha chun aghaidh a thabhairt ar iarmhairtí ghéarchéim COVID-19
Extraordinary and temporary additional means to address the consequences of the COVID-19 crisis
Tá earnáil an iompair buailte go han-dona ag géarchéim COVID-19.
The COVID-19 crisis has hit the transport sector exceptionally hard.
Teorainneacha ama a chur siar ar bhonn roghnach atá ann de dheasca phaindéim COVID-19
Optional deferral of time limits because of the COVID-19 pandemic
I bhfianaise an mhéadaithe scáfair ar líon na gcásanna COVID-19 sna Ballstáit, ina theachtaireacht an 17 Meitheamh 2020, mhol an Coimisiún straitéis AE le haghaidh vacsaíní COVID-19.
In view of the alarming increase in the number of COVID-19 cases in the Member States, in its communication of 17 June 2020 the Commission has proposed an EU strategy for COVID-19 vaccines.
Chuige sin, ba cheart ligean do na Ballstáit ráta laghdaithe CBL a chur i bhfeidhm ar sholáthar feistí leighis diagnóiseacha in vitro COVID-19 seirbhísí a bhfuil dlúthnasc acu leis na feistí sin, nó díolúine a dheonú lena ngabhann in-asbhainteacht CBL arna íoc ag an gcéim roimhe sin i ndáil le soláthar vacsaíní COVID-19 agus feistí leighis diagnóiseacha in vitro COVID-19, arna bhformheas sa cháil sin ag an gCoimisiún nó acu féin, chomh maith le seirbhísí a bhfuil dlúthnasc acu leis na vacsaíní agus na feistí sin.
To that end, Member States should be allowed to apply a reduced VAT rate to the supply of COVID-19 in vitro diagnostic medical devices and services closely linked to such devices, or to grant an exemption with deductibility of VAT paid at the preceding stage in respect of the supply of COVID-19 vaccines and in vitro diagnostic medical devices, approved as such by the Commission or by them, as well as of services closely linked to such vaccines and devices.
An fhéidearthacht ráta laghdaithe CBL a chur i bhfeidhm ar sholáthar feistí leighis diagnóiseacha in vitro COVID-19 agus seirbhísí a bhfuil dlúthnasc acu leis na feistí sin nó díolúine a dheonú lena ngabhann inasbhainteacht CBL arna íoc ag an gcéim roimhe sin i dtaca le soláthar vacsaíní COVID-19 agus feistí leighis diagnóiseacha in vitro COVID-19 a dhíolmhú ó CBL, chomh maith le seirbhísí a bhfuil dlúthnasc acu leis na vacsaíní agus na feistí sin, ba cheart an fhéidearthacht sin a bheith teoranta ó thaobh ama de.
The possibility to apply a reduced VAT rate to the supply of COVID-19 in vitro diagnostic medical devices and services closely linked to such devices or to grant an exemption with deductibility of VAT paid at the preceding stage in respect of the supply of COVID-19 vaccines and in vitro diagnostic medical devices and services closely linked to such vaccines and devices, should be limited in time.
Ní thugtar aghaidh leis an Airteagal sin, áfach, ar chásanna cosúil le ráig COVID‐19.
However, that Article does not address situations like the outbreak of COVID-19.
Tá iarmhairtí ráig COVID-19 dulta i bhfeidhm ar na Ballstáit ar shlí ar leith.
Member States have been affected by the consequences of the COVID-19 outbreak in a unique manner.
Tá iarmhairtí ráig COVID-19 dulta i bhfeidhm ar na Ballstáit ar shlí gan fasach.
Member States have been affected by the consequences of the COVID-19 outbreak in an unprecedented manner.
Bearta eisceachtúla chun Cistí SIE a úsáid mar fhreagairt ar ráig COVID-19
Exceptional measures for the use of the ESI Funds in response to the COVID-19 outbreak
gurb í ráig COVID-19 is cúis leis an oibríocht a bheith ar fionraí;
the suspension of the operation is due to the outbreak of COVID-19;
gurb í ráig COVID-19 is cúis leis na gníomhachtaí a bheith ar fionraí;
the suspension of the actions is due to the outbreak of COVID-19;
Meastar gur ard an dóchúlacht go ndéanfar COVID-19 a tharchur a thuilleadh san Aontas.
The probability of further transmission of COVID‐19 in the Union is considered high.
Is ollmhór suaiteach an tionchar atá ag ráig COVID-19 ar chórais eacnamaíocha na mBallstát uile.
The COVID-19 outbreak has had a massive and disruptive impact on the economic system of each Member State.
Tá baint dhíreach ag na fadhbanna leachtachta sin le paindéim COVID-19.
Those liquidity problems are directly linked to the COVID-19 pandemic.
Bearta éigeandála a bhaineann le paindéim COVID-19
Emergency measures linked to the COVID-19 pandemic
Tá tionchar diúltach tromchúiseach á imirt ag ráig COVID-19 ar earnáil an mhuiriompair.
The COVID-19 outbreak is having a serious negative impact on the maritime transport sector.
Róluaineachtaí a eisiamh ó ríomh na suiminne cúltástála i bhfianaise phaindéim COVID-19
Exclusion of overshootings from the calculation of the back-testing addend in view of the COVID-19 pandemic
An 11 Márta 2020, shainigh EDS COVID-19 mar phaindéim.
On 11 March 2020, WHO characterised COVID-19 as a pandemic.
Is galar aimpléiseach é COVID-19 a chuireann isteach ar phróisis fhiseolaíocha iolracha.
COVID-19 is a complex disease that affects multiple physiological processes.
An 11 Márta 2020, dhearbhaigh EDS gur paindéim ráig COVID-19.
On 11 March 2020, the WHO declared the COVID-19 outbreak a pandemic.
Chuaigh paindéim COVID-19 i bhfeidhm ar Bhallstáit uile an Aontais.
The COVID-19 pandemic has affected all Member States.
An 11 Márta 2020, dhearbhaigh EDS gur paindéim í ráig COVID-19.
On 11 March 2020, the WHO declared the COVID‐19 outbreak a pandemic.
Chuaigh paindéim COVID-19 i bhfeidhm ar Bhallstáit uile an Aontais.
The COVID‐19 pandemic has affected all Member States.